
Felix Dobbs, Broken String Biosciences CEO
Exclusive: Backed by Illumina, Broken String Biosciences raises $15M to find off-target gene edits
Broken String Biosciences has raised $15 million for its off-target sequencing service for gene editing companies.
The Series A round was led by Illumina Ventures …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.